In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Marty Tenenbaum, PhD Founder of Cancer Commons

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

  • I appreciated the quick response after my registration with Cancer Commons. The nurse navigator was prompt and compassionate. I knew my request wasn’t going to be buried and didn’t have time to wonder how long it would take before I got a response. The scientist Lauren connected me too was very prompt in giving me answers to my question. And when I asked questions... Read more »

    Gail Lung cancer patient
  • Lola helped us tremendously in navigating the process with Cancer Commons, taking the time to explain findings. The Cancer Commons report is very helpful in exploring treatment alternatives that my oncologists may not have considered yet.

    Francois
    Pancreatic cancer patient

  • Tim is so helpful and we were so impressed with the detailed treatment options report that he sent. This cancer journey is overwhelming and it is comforting to have these services. A heartfelt thanks to Cancer Commons.

    Jill
    Glioblastoma patient

  • My experience with Cancer Commons has been fantastic! Their support and advice have been extremely helpful. I will always be very greatful to the Cancer Commons team. They took the time to contact me by phone to learn more about my diagnosis so they could study my case and recommend options to consider. Thanks so much to all the people involved.

    Michael Goold
    Grade 4 glioblastoma patient

  • Emma has been wonderful. She has been in touch regularly.

    Elise
    Ovarian cancer patient

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.